How Much Did GenRx Raise?
Funding & Key Investors

GenRx has successfully secured a significant capital injection, bringing its total funding to $831K. This latest infusion, characterized by a $481K strategic investment, underscores the company's robust growth trajectory within the competitive pharmaceutical services sector. By leveraging these financial resources, the Scottsdale-based entity is positioned to fortify its infrastructure and expand its patient-centric medication therapy offerings.

What is GenRx?

GenRx
RetailDrug Stores & Pharmacies

GenRx operates as a specialized pharmacy provider headquartered in Scottsdale, Arizona, dedicated to streamlining pharmaceutical care for both new and existing patients. The firm distinguishes itself through a commitment to reliable medication access, particularly during periods of supply chain volatility or local delivery disruptions. By prioritizing direct communication channels and personalized patient support, GenRx has carved out a niche in the healthcare market, focusing on the intersection of clinical efficacy and logistical reliability. Its operational model is designed to mitigate the common friction points associated with traditional pharmacy services, ensuring that patients receive consistent care and therapeutic guidance.

The company's market position is reinforced by its focus on high-touch service, which serves as a critical differentiator in an industry increasingly dominated by automated, impersonal platforms. As GenRx continues to scale, its emphasis on patient outcomes and service continuity remains the cornerstone of its business strategy.

How much funding has GenRx raised?

GenRx has raised a total of $831K across 2 funding rounds:

2020

Debt

$350K

2021

Debt

$481K

Debt (2020): $350K with participation from PPP

Debt (2021): $481K led by PPP

Key Investors in GenRx

PPP

Public-Private Partnership

What's next for GenRx?

With the recent influx of capital, GenRx is poised to accelerate its operational capabilities and enhance its service delivery network. The strategic focus will likely shift toward optimizing its logistical framework to further insulate patients from external delivery delays, while simultaneously expanding its reach to a broader demographic of residents. As the company matures, the integration of advanced pharmaceutical management tools and the scaling of its direct-to-patient support infrastructure will be paramount. This phase of development is critical for GenRx to transition from a localized service provider to a more comprehensive enterprise-level player in the pharmaceutical landscape, ensuring long-term sustainability and market relevance in an evolving healthcare ecosystem.

See full GenRx company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Retail industry

Office Products Retail & DistributionRetailHome Improvement & Hardware Retail
Automobile DealersRetail
Office Products Retail & DistributionRetailIndustrial Machinery & EquipmentManufacturingOther Rental Stores (Furniture, A/V, Construction & Industrial Equipment)
Flowers, Gifts & Specialty StoresRetailRecord, Video & Book Stores

Frequently Asked Questions Regarding GenRx Financial Insights

What are the most recent funding rounds that GenRx has completed, and what were the funding rounds?
GenRx has recently completed 2 funding rounds: Debt on Feb 12, 2021, Debt on Apr 7, 2020.
What is the total amount of funding GenRx has raised to date?
GenRx has raised a total of $831K in funding to date.
How many funding rounds has GenRx completed?
GenRx has completed 2 funding rounds.
How much funding did GenRx raise in its most recent funding round?
GenRx raised $481K in its most recent funding round.
Who are the lead investors in GenRx's latest funding round?
The lead investor in GenRx's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in GenRx's history?
The largest funding round in GenRx's history was $481K.
See more information about GenRx